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Does the asthma control test reflect
inflammation?   
L'"asthma control test" riflette davvero
l’infiammazione?  
Margherita Neri  
School of Specialization in Occupational Medicine, University of Pavia, Pavia, Italy
The present issue of Multidisciplinary Respiratory
Medicine includes a paper by Bora et al. [1] inves-
tigating the relationship between the asthma con-
trol test (ACT) and airway inflammation. In a group
of stable asthmatic patients admitted to a pul-
monary outpatient clinic, the authors carried out
the ACT, pulmonary function tests, methacholine
bronchial provocation test (MBPT), fractional ex-
haled nitric oxide level (FeNO), and induced spu-
tum test. All these parameters were re-evaluated at
the third month after adjusting patients’ medica-
tions according to baseline ACT scores. In the pa-
per there is no description of the adjustments made
to the therapy.
The conclusion of the authors is that, although ACT
scores did not show significant correlations with
the airway inflammation parameters tested in the
study, a marked reduction in the percentage of pa-
tients with MBPT positivity and FeNO > 20 ppb in
the follow up may underscore the importance of fo-
cusing on the control concept in the management
of asthma.
Today asthma treatment is based not only on as-
sessing asthma severity, but also on achieving and
maintaining asthma control [2-4]. There is general
agreement that a great proportion of people with
asthma are not optimally controlled [5,6]. 
Over a period of several years, numerous tools have
been developed to determine the level of asthma
control with the main aim of guiding treatment
changes [7-9]. A step-up in treatment is recom-
mended in order to achieve asthma control in un-
controlled patients and a step-down is suggested in
well controlled patients [2]. ACT has been shown
to be useful in the detection of poorly controlled
asthma both in adults and children [9-11]. 
ACT is a 5-item, self-completed questionnaire. The
five items evaluate: limitation of daily activities,
shortness of breath, night-time waking, use of re-
liever medication and the patient’s perception of
asthma control in the 4 weeks prior [9,10]. For each
question there are five possible answers, scored
from 1 to 5. The total ACT score is the sum of the
scores attributed to the five questions, ranging from
5 (poorest asthma control) to 25 (optimal asthma
control). ACT has been validated for adult asthmat-
ic patients and there is also a validated version for
children [11]. It is accepted that a score lower than
19 indicates poorly controlled asthma.
Since its validation and publication, ACT has been
used extensively in clinical trials, mainly because it
allows a more “objective” evaluation of asthma
control than that performed by the physician during
a “spot” visit [11-13]. Moreover, it has been
demonstrated that patients also tend to overesti-
mate the level of asthma control and sometimes al-
so the extent of improvement achieved after thera-
py [12,13]. Finally, previous studies have also con-
firmed the reliability of the ACT score in guiding
clinical decisions [14,15].
In Bora et al.'s study the ACT score did not signifi-
cantly correlate with airway inflammation parame-
ters and did not change from baseline visit (mean
ACT score = 18.98 ± 4.59) to follow up visit (mean
ACT score = 19.65 ± 4.11), and patients had good
baseline respiratory function (mean FEV1 = 93.9 ±
13.7%), without significant modification at follow
up. Interestingly, despite the lack of respiratory
function and ACT score changes, there was a statis-
tically significant reduction in the percentage of pa-
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tients with MBPT positivity (from 59% to 45% of
patients, p = 0.029) and FeNO > 20 ppb (from 15
to 14, p = 0.025) at the follow up visit.
These findings could confirm the importance of fo-
cusing on control in the management of asthma, as
the ACT is a very simple test, and more rapid to per-
form than a complete spirometry, obviously not
burdening for patients or potentially “at risk” as
MBPT or FeNO test. This study confirms that ACT
can be widely used in clinical practice, but it does
not give reliable information and does not correlate
with airway inflammation. 
